Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

NCT00492700 is registered in ClinicalTrials.gov with Association pour la Recherche sur les Maladies Hépatiques Virales as lead sponsor.

NCT NCT00492700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Lead sponsor
Association pour la Recherche sur les Maladies Hépatiques Virales
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
Not reported
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic steatohepatitis